Product Images Topiramate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Topiramate NDC 70518-0370 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

This is a description of Topiramate 25 mg tablets, with a quantity of 90 tablets in the packaging. The medication is manufactured by Cipla Ltd in Kurkumbh, India. The NDC number for the product is 70518-0370-01. It is important to keep this medication out of the reach of children and follow the directions for use as provided in the package insert. Store the tablets at a temperature between 20-25°C (58-77°F) with excursions permitted to 15-30°C (59-86°F) as per USP guidelines. The product has been repackaged by RemedyRepack Inc. in Indiana, PA. When in doubt, consult a healthcare professional.*

ccb7a1e4 a3a1 4a0e 8eb0 8086f53e314b 01

ccb7a1e4 a3a1 4a0e 8eb0 8086f53e314b 01

ccb7a1e4 a3a1 4a0e 8eb0 8086f53e314b 02

ccb7a1e4 a3a1 4a0e 8eb0 8086f53e314b 02

ccb7a1e4 a3a1 4a0e 8eb0 8086f53e314b 03

ccb7a1e4 a3a1 4a0e 8eb0 8086f53e314b 03

This information pertains to a study evaluating the change in the average monthly migraine period rate during a double-blind phase using different dosages of Topamax (100 mg/day and 200 mg/day). The results show an increase of 56% compared to the baseline measurement. Additionally, statistical significance was observed with p-values indicating a high level of confidence in the findings.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.